Metastatic Malignant Solid Neoplasm Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • La Jolla, California
  • +8 more
2022-04-06
Apr 6, 2022
N
Recruiting
  • Metastatic Malignant Solid Neoplasm
  • Unresectable Solid Neoplasm
  • Edodekin alfa
  • Pembrolizumab
  • La Jolla, California
  • +27 more
2022-04-05
Apr 5, 2022
N
Recruiting
  • Advanced Malignant Solid Neoplasm
  • +13 more
  • Nivolumab
  • Birmingham, Alabama
  • +43 more
2022-04-05
Apr 5, 2022
N
Active, not recruiting
  • Ann Arbor Stage III Lymphoma
  • +4 more
  • Bethesda, Maryland
  • +2 more
2022-04-05
Apr 5, 2022
N
Recruiting
  • Metastatic Malignant Solid Neoplasm
  • +3 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • Cleveland, Ohio
  • +1 more
2022-04-05
Apr 5, 2022
N
N
Recruiting
  • Lymphoma
  • +6 more
  • Cytology Specimen Collection Procedure
  • Birmingham, Alabama
  • +139 more
2022-04-05
Apr 5, 2022
N
Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +20 more
  • Pembrolizumab
  • Ziv-Aflibercept
  • Tampa, Florida
  • +8 more
2022-04-05
Apr 5, 2022
N
Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
2022-04-05
Apr 5, 2022
N
Recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Copanlisib Hydrochloride
  • +2 more
  • Aurora, Colorado
  • +7 more
2022-04-01
Apr 1, 2022
N
Recruiting
  • Advanced Breast Carcinoma
  • +55 more
  • Bethesda, Maryland
  • +1 more
2022-04-01
Apr 1, 2022
S
Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Educational Intervention
  • +3 more
  • Fairbanks, Alaska
  • +152 more
2022-03-29
Mar 29, 2022
N
Recruiting
  • Metastatic Colorectal Carcinoma
  • +29 more
  • Los Angeles, California
  • +22 more
2022-03-29
Mar 29, 2022
N
Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +8 more
  • Dabrafenib Mesylate
  • +2 more
  • Los Angeles, California
  • +15 more
2022-03-25
Mar 25, 2022
M
Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +3 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-24
Mar 24, 2022
A
Recruiting
  • CDK Gene Mutation
  • +5 more
  • Anchorage, Alaska
  • +385 more
2022-03-22
Mar 22, 2022
N
Recruiting
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center LAO
2022-03-22
Mar 22, 2022
N
Active, not recruiting
  • COVID-19 Infection
  • +3 more
  • Biospecimen Collection
  • +3 more
  • Birmingham, Alabama
  • +940 more
2022-03-19
Mar 19, 2022